Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer
- PMID: 37716504
- DOI: 10.1016/j.lfs.2023.122084
Recent progress on the effect of extracellular matrix on occurrence and progression of breast cancer
Abstract
Breast cancer (BC) metastasis is an enormous challenge targeting BC therapy. The extracellular matrix (ECM), the principal component of the BC metastasis niche, is the pivotal driver of breast tumor development, whose biochemical and biophysical characteristics have attracted widespread attention. Here, we review the biological effects of ECM constituents and the influence of ECM stiffness on BC metastasis and drug resistance. We provide an overview of the relative signal transduction mechanisms, existing metastasis models, and targeted drug strategies centered around ECM stiffness. It will shed light on exploring more underlying targets and developing specific drugs aimed at ECM utilizing biomimetic platforms, which are promising for breast cancer treatment.
Keywords: Breast cancer metastasis; Extracellular matrix stiffness; Matrix models; Targeting drugs.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that there are no conflicts of interest.
Similar articles
-
The biomimetic extracellular matrix: a therapeutic tool for breast cancer research.Transl Res. 2022 Sep;247:117-136. doi: 10.1016/j.trsl.2021.11.008. Epub 2021 Nov 27. Transl Res. 2022. PMID: 34844003 Review.
-
Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.Front Oncol. 2021 Apr 22;11:650453. doi: 10.3389/fonc.2021.650453. eCollection 2021. Front Oncol. 2021. PMID: 33968752 Free PMC article. Review.
-
Extracellular matrix components in breast cancer progression and metastasis.Breast. 2013 Aug;22 Suppl 2:S66-72. doi: 10.1016/j.breast.2013.07.012. Breast. 2013. PMID: 24074795 Review.
-
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.J Hematol Oncol. 2022 Mar 24;15(1):34. doi: 10.1186/s13045-022-01252-0. J Hematol Oncol. 2022. PMID: 35331296 Free PMC article. Review.
-
Mammary epithelium-specific inactivation of V-ATPase reduces stiffness of extracellular matrix and enhances metastasis of breast cancer.Mol Oncol. 2018 Feb;12(2):208-223. doi: 10.1002/1878-0261.12159. Epub 2017 Dec 12. Mol Oncol. 2018. PMID: 29178186 Free PMC article.
Cited by
-
N7-Methylguanine-Related Gene Signature Highlights EIF4E as a Novel Therapeutic Target in HER2-Negative Breast Cancer.J Cell Mol Med. 2025 Aug;29(16):e70808. doi: 10.1111/jcmm.70808. J Cell Mol Med. 2025. PMID: 40842081 Free PMC article.
-
Unveiling Collagen's Role in Breast Cancer: Insights into Expression Patterns, Functions and Clinical Implications.Int J Gen Med. 2024 May 2;17:1773-1787. doi: 10.2147/IJGM.S463649. eCollection 2024. Int J Gen Med. 2024. PMID: 38711825 Free PMC article. Review.
-
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production.Curr Issues Mol Biol. 2024 May 13;46(5):4646-4687. doi: 10.3390/cimb46050282. Curr Issues Mol Biol. 2024. PMID: 38785550 Free PMC article. Review.
-
Missense mutations of GPER1 in breast invasive carcinoma: Exploring gene expression, signal transduction and immune cell infiltration with insights from cellular pharmacology.Biomed Rep. 2024 Nov 29;22(2):22. doi: 10.3892/br.2024.1900. eCollection 2025 Feb. Biomed Rep. 2024. PMID: 39720300 Free PMC article.
-
Single-cell analysis of matrisome-related genes in breast invasive carcinoma: new avenues for molecular subtyping and risk estimation.Front Immunol. 2024 Oct 18;15:1466762. doi: 10.3389/fimmu.2024.1466762. eCollection 2024. Front Immunol. 2024. PMID: 39493752 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources